Showing results (121-130 of 9,399) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|May 1, 1979
Problems of university-based scientists associated with clinical trialsR D RemingtonClinical Pharmacology and Therapeutics|May 1, 1979
Effective clinical trials investigators and adequate incentivesJ StamlerClinical Pharmacology and Therapeutics|May 1, 1979
Publications and promotions for the clinical investigatorA S RelmanClinical Pharmacology and Therapeutics|December 10, 2022
Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric PatientsGuimu Guo, Xiang You, Wanhong Wu, et al.Clinical Pharmacology and Therapeutics|December 10, 2022
Multi-Omics Studies in Historically Excluded Populations: The Road to EquityGuang Yang, Mrinal Mishra, Minoli A PereraClinical Pharmacology and Therapeutics|November 23, 2022
Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention StudiesLauren R Cirrincione, Victoria Luna Brennan Grieve, Jay Holloway, et al.Clinical Pharmacology and Therapeutics|August 1, 1987
Trimethoprim pharmacokinetics in children with renal insufficiencyK Hoppu, O Koskimies, J TuomistoClinical Pharmacology and Therapeutics|August 1, 1987
Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapyD M Salerno, P J Sharkey, G A Granrud, et al.Clinical Pharmacology and Therapeutics|August 1, 1987
Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertensionT Baba, T Ishizaki, S Murabayashi, et al.Clinical Pharmacology and Therapeutics|April 4, 2020
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From PatientsElena Genova, Federica Cavion, Marianna Lucafò, et al.Pageof 940